Business Description
Xcell Therapeutics Inc
ISIN : KR7373110006
Description
Xcell Therapeutics Inc operates as a research company engaged in development of regenerative medicines. The company is developing proliferation media for various animal cell types.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -0.26 | |||||
| Debt-to-Equity | -3.6 | |||||
| Debt-to-EBITDA | -1.98 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -2.35 | |||||
| Beneish M-Score | -3.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.5 | |||||
| 3-Year EBITDA Growth Rate | 28.8 | |||||
| 3-Year EPS without NRI Growth Rate | 11.5 | |||||
| 3-Year FCF Growth Rate | 20.6 | |||||
| 3-Year Book Growth Rate | 13.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.77 | |||||
| 9-Day RSI | 58.79 | |||||
| 14-Day RSI | 57.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.29 | |||||
| Quick Ratio | 0.12 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 251.23 | |||||
| Days Sales Outstanding | 130.24 | |||||
| Days Payable | 137.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -36.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -49.74 | |||||
| Operating Margin % | -412.71 | |||||
| Net Margin % | -440.86 | |||||
| FCF Margin % | -295.64 | |||||
| ROA % | -50.53 | |||||
| ROIC % | -35.48 | |||||
| 3-Year ROIIC % | 364.33 | |||||
| ROC (Joel Greenblatt) % | -74.85 | |||||
| ROCE % | -222.83 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 77.45 | |||||
| EV-to-EBIT | -22.72 | |||||
| EV-to-EBITDA | -28.05 | |||||
| EV-to-Revenue | 98.38 | |||||
| EV-to-FCF | -33.13 | |||||
| Earnings Yield (Greenblatt) % | -4.4 | |||||
| FCF Yield % | -3.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Xcell Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 1,000.021 | ||
| EPS (TTM) (â‚©) | -481 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 57.76 | ||
| 14-Day ATR (â‚©) | 913.481248 | ||
| 20-Day SMA (â‚©) | 7615 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (â‚©) | 4545 - 12900 | ||
| Shares Outstanding (Mil) | 10.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Xcell Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Xcell Therapeutics Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Xcell Therapeutics Inc Frequently Asked Questions
What is Xcell Therapeutics Inc(XKRX:373110)'s stock price today?
The current price of XKRX:373110 is â‚©8450.00. The 52 week high of XKRX:373110 is â‚©12900.00 and 52 week low is â‚©4545.00.
When is next earnings date of Xcell Therapeutics Inc(XKRX:373110)?
The next earnings date of Xcell Therapeutics Inc(XKRX:373110) is .
Does Xcell Therapeutics Inc(XKRX:373110) pay dividends? If so, how much?
Xcell Therapeutics Inc(XKRX:373110) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers